An interventional study of Subacromial Injection in Subacromial Impingement Syndrome, sponsored by Aneurin Bevan University Health Board. Status unknown at 1 site in United Kingdom. Per ClinicalTrials.gov, last updated 2018-10-02.
Sponsored by Aneurin Bevan University Health Board · Not applicable, Interventional, and Diagnostic
Subacromial shoulder injections can be approached from the front or side of the shoulder. The investigators are comparing both methods, to find which one has better spread in the subacromial space.
Both lateral and posterio-lateral methods of subacromial injections are widely used for diagnostic and therapeutic purposes. It is not known which method allows the most accurate access into the subacromial space and is more effective.
The investigators have been using a novel approach from the anterior aspect of the shoulder for years with good clinical effect and propose comparing this approach to the described approach. This study will indicate which method is best and will be of practical clinical importance. The investigators feel the technique is easier to perform than other described methods and could be taught to clinicians throughout the country and adopted as the standard approach.
320 studies on the registry are indexed under Shoulder Impingement Syndrome; 62 are open to participants now.
This study's planned enrollment of 100 is above the median of 54 across 271 interventional studies indexed under Shoulder Impingement Syndrome.
Browse Shoulder Impingement Syndrome studies →Aneurin Bevan University Health Board is the lead sponsor of 3 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Injection in to subacromial space from anterior portal
Procedure: Subacromial Injection
Injection in to subacromial space from lateral portal
Procedure: Subacromial Injection
Injection in to subacromial space in the shoulder from anterior portal
The spread of dye in subacromial space
The participants will go for an X ray following injection which contains a radio-opaque dye to demonstrate the spread of injected material (Local anaesthetic, depomedrone and Niopam dye) in the subacromial space. A blinded radiologist will read the radiographs and scale the distribution of dye from 1 to 4 depending on the location of radiopaque dye.
Time frame: With in One hour
Pain control after subacromial injection
The participants will fill a visual analog score before and after injection to assess the pain relief after injection.
Time frame: With in One hour
Plan to share: Undecided
Started Dec 2017 (actual). Primary completion is estimated for Feb 2019, 14 months after the start.
Of 170 non-industry interventional studies with no phase under Shoulder Impingement Syndrome, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 24. This study's planned 14 months is above that.
Counting every sponsor, half of 172 studies reached it within 12 months; a quarter within 5 and three quarters within 24.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Sep 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Shoulder Impingement Syndrome →
Aneurin Bevan University Health Board